| Product Code: ETC10073316 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Emetogenic Drugs Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Emetogenic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Emetogenic Drugs Market - Industry Life Cycle |
3.4 Vietnam Emetogenic Drugs Market - Porter's Five Forces |
3.5 Vietnam Emetogenic Drugs Market Revenues & Volume Share, By Class, 2021 & 2031F |
3.6 Vietnam Emetogenic Drugs Market Revenues & Volume Share, By Types of Emesis, 2021 & 2031F |
3.7 Vietnam Emetogenic Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Vietnam Emetogenic Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.9 Vietnam Emetogenic Drugs Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Vietnam Emetogenic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer and other chronic diseases requiring chemotherapy, leading to higher demand for emetogenic drugs in Vietnam. |
4.2.2 Growing awareness about the importance of managing chemotherapy-induced nausea and vomiting, driving the adoption of emetogenic drugs. |
4.2.3 Expansion of healthcare infrastructure and improving access to healthcare services, facilitating the distribution and availability of emetogenic drugs in Vietnam. |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for pharmaceutical products in Vietnam, potentially delaying the market entry of new emetogenic drugs. |
4.3.2 Limited healthcare budget and reimbursement policies, affecting the affordability and accessibility of emetogenic drugs for patients in Vietnam. |
5 Vietnam Emetogenic Drugs Market Trends |
6 Vietnam Emetogenic Drugs Market, By Types |
6.1 Vietnam Emetogenic Drugs Market, By Class |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Emetogenic Drugs Market Revenues & Volume, By Class, 2021- 2031F |
6.1.3 Vietnam Emetogenic Drugs Market Revenues & Volume, By Serotonin Receptor Antagonists (5-HT3 RAS), 2021- 2031F |
6.1.4 Vietnam Emetogenic Drugs Market Revenues & Volume, By Neurokinin-1 Receptor Antagonist (NK1 RAS), 2021- 2031F |
6.1.5 Vietnam Emetogenic Drugs Market Revenues & Volume, By 5HT3 RA/NK1 RA Combination, 2021- 2031F |
6.1.6 Vietnam Emetogenic Drugs Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.1.7 Vietnam Emetogenic Drugs Market Revenues & Volume, By Olanzapine, 2021- 2031F |
6.1.8 Vietnam Emetogenic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Vietnam Emetogenic Drugs Market, By Types of Emesis |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Emetogenic Drugs Market Revenues & Volume, By Acute, 2021- 2031F |
6.2.3 Vietnam Emetogenic Drugs Market Revenues & Volume, By Delayed, 2021- 2031F |
6.2.4 Vietnam Emetogenic Drugs Market Revenues & Volume, By Anticipatory, 2021- 2031F |
6.2.5 Vietnam Emetogenic Drugs Market Revenues & Volume, By Breakthrough, 2021- 2031F |
6.2.6 Vietnam Emetogenic Drugs Market Revenues & Volume, By Refactory, 2021- 2031F |
6.2.7 Vietnam Emetogenic Drugs Market Revenues & Volume, By Chronic, 2021- 2031F |
6.3 Vietnam Emetogenic Drugs Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Emetogenic Drugs Market Revenues & Volume, By Highly Emetogenic Chemotherapy, 2021- 2031F |
6.3.3 Vietnam Emetogenic Drugs Market Revenues & Volume, By Moderately Emetogenic Chemotherapy, 2021- 2031F |
6.3.4 Vietnam Emetogenic Drugs Market Revenues & Volume, By Low Emetogenic Chemotherapy, 2021- 2031F |
6.3.5 Vietnam Emetogenic Drugs Market Revenues & Volume, By Other, 2021- 2031F |
6.4 Vietnam Emetogenic Drugs Market, By Drug Type |
6.4.1 Overview and Analysis |
6.4.2 Vietnam Emetogenic Drugs Market Revenues & Volume, By Branded, 2021- 2031F |
6.4.3 Vietnam Emetogenic Drugs Market Revenues & Volume, By Generic, 2021- 2031F |
6.5 Vietnam Emetogenic Drugs Market, By End user |
6.5.1 Overview and Analysis |
6.5.2 Vietnam Emetogenic Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Vietnam Emetogenic Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Vietnam Emetogenic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Vietnam Emetogenic Drugs Market Import-Export Trade Statistics |
7.1 Vietnam Emetogenic Drugs Market Export to Major Countries |
7.2 Vietnam Emetogenic Drugs Market Imports from Major Countries |
8 Vietnam Emetogenic Drugs Market Key Performance Indicators |
8.1 Patient compliance rate with emetogenic drug regimens. |
8.2 Rate of adverse events related to emetogenic drugs. |
8.3 Number of healthcare facilities offering emetogenic drugs education programs. |
9 Vietnam Emetogenic Drugs Market - Opportunity Assessment |
9.1 Vietnam Emetogenic Drugs Market Opportunity Assessment, By Class, 2021 & 2031F |
9.2 Vietnam Emetogenic Drugs Market Opportunity Assessment, By Types of Emesis, 2021 & 2031F |
9.3 Vietnam Emetogenic Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Vietnam Emetogenic Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.5 Vietnam Emetogenic Drugs Market Opportunity Assessment, By End user, 2021 & 2031F |
10 Vietnam Emetogenic Drugs Market - Competitive Landscape |
10.1 Vietnam Emetogenic Drugs Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Emetogenic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here